Dr. Baumgartner joins Applied as an accomplished global drug development leader with over 35 years of experience in senior regulatory, clinical development, and medical affairs roles. He has held a ...

This helps explain why Sullivan and my tattoos haven’t faded, while Kwarteng’s, on her hip, has. Bhanusali says that in ...

Underscoring the "pious intention" of compassionate appointment which is to give relief to the deceased employee's kin, the ...

TORONTO, March 19, 2025 (GLOBE NEWSWIRE) -- Kinross Gold Corporation (“Kinross” or the “Company”) (TSX: K, NYSE: KGC) is pleased to announce that the Toronto Stock Exchange (the “TSX”) has accepted ...

VSee Health (NASDAQ: VSEE), a rapidly growing leader in AI-powered telehealth, is redefining the $787 billion digital healthcare market with its modular, no-code/low-code platform. Trusted by more ...

Becker’s asked C-suite executives from hospitals and health systems across the U.S. to share their biggest lesson from the ...

The Senate voted mostly along party lines Friday afternoon to pass the House Republican-drafted bill to fund government through September, avoiding a government shutdown only hours before funding ...

Vuzix® Corporation (NASDAQ: VUZI), ("Vuzix" or, the "Company"), a leading supplier of AI-powered Smart glasses, waveguides and Augmented Reality (AR) technologies, today announced that the Company has ...

Today, VSee Health has issued the following letter to shareholders from Co-CEOs Milton Chen, PhD and Imo Aisiku, MD. Dear VSEE Shareholders: VSee Health entered 2025 with strong momentum ...

MATTERHORN is the first global phase 3 trial to show improved event-free survival with an immunotherapy combo vs standard ...

Danii Pollehn/Adobe Stock If you, too, got an ADHD diagnosis in adulthood, you’ve probably had a lot of “ah hah” moments when ...